- /
- Supported exchanges
- / ST
- / IDLDX.ST
Neovici Holding AB (publ) (IDLDX ST) stock market data APIs
Neovici Holding AB (publ) Financial Data Overview
IDL Diagnostics AB (publ), a vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden. It offers UBC Rapid, a point-of-care test for diagnosis and monitoring of bladder cancer; AroCell TK 210 ELISA, a biomarker for tumor cells; and TUBEX TF, a vitro diagnostic test for detection of acute typhoid fever. Its vitro diagnostic biomarkers are used in breast, bladder, and prostate cancer therapies. The company was formerly known as AroCell AB (publ) and changed its name to IDL Diagnostics AB (publ) in May 2025. IDL Diagnostics AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Neovici Holding AB (publ) data using free add-ons & libraries
Get Neovici Holding AB (publ) Fundamental Data
Neovici Holding AB (publ) Fundamental data includes:
- Net Revenue: 53 108 K
- EBITDA: -9 463 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Neovici Holding AB (publ) News
New
European Penny Stocks To Watch: 3 Picks With Market Caps Over €30M
The European market has shown resilience, with the STOXX Europe 600 Index gaining ground thanks to robust economic data and encouraging earnings results. Amid this backdrop, penny stocks—though ofte...
European Penny Stocks To Consider In November 2025
As European markets grapple with concerns over the valuation of artificial intelligence stocks, major indices like the STOXX Europe 600 have seen declines. Despite these challenges, opportunities stil...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.